483
GLPGCP Development (Asia) Pte. Ltd.GLPGCP Development (Asia) Pte. Ltd. – FDA 483, Jan 30, 2026
Record Details
An FDA inspection of GLPGCP Development (Asia) Pte. Ltd. in Singapore identified two objectionable conditions related to bioanalytical activities and method validation. The firm failed to consistently follow standard operating procedures for documenting system suitability sample failures and inaccurately recorded method validation activities in source records.
View Company Profile
ID · 3a2a3d7b-ae6a-487c-9a90-0d731754259a
Other documents for GLPGCP Development (Asia) Pte. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.